Brief: Accustem Sciences, Inc. Signs Agreement To Access Blood Samples From Lung Cancer Screening Trial To Expedite Msc Commercialization Plan
16/04/2025 12:19
April 16 (Reuters) - AccuStem Sciences Inc ACUT.PK: ACCUSTEM SCIENCES, INC. SIGNS AGREEMENT TO ACCESS BLOOD SAMPLES FROM LUNG CANCER SCREENING TRIAL TO EXPEDITE MSC COMMERCIALIZATION PLAN Source text: ID:nGNX26bG7k Further company coverage: ACUT.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ACCUSTEM SCIENCES
See all newsBrief: AccuStem Sciences And EmeritusDX Announce Partnership To Commercialize MSC Test For Lung Cancer Screening
Brief: Accustem Sciences, Inc. Signs Agreement To Access Blood Samples From Lung Cancer Screening Trial To Expedite Msc Commercialization Plan
Brief: Accustem Sciences, Inc. And Emeritusdx Announce Joint Product Development Agreement And Strategic Partnership
Brief: Accustem Sciences Ltd Applies To List Common Stock On Nasdaq Under Symbol “ACUT” - SEC Filing